Abstract:Aminoacyl-tRNA synthetases (aaRSs) are promising drug targets due to their essential roles in protein translation. Although current inhibitors primarily occupy one or two of the three substrate binding sites on aaRSs, we report here the structure-based design of the first class of triple-site aaRS inhibitors by targeting Salmonella enterica threonyl-tRNA synthetase (SeThrRS). Competition of our compounds with all three substrates on SeThrRS binding was confirmed via isothermal titration calorimetry assays. Cocrystal structures of three compounds bound to SeThrRS unambiguously confirmed their substrate-mimicking triple-site binding mode. Compound 36j exhibited the best enzyme activity against SeThrRS with IC50 = 19 nM and Kd = 35.4 nM. Compounds 36b, 36k, and 36l exhibited antibacterial activities with minimum inhibitory concentration values of 2–8 μg/mL against the tested bacteria, which are superior to those of the reported dual-site ThrRS inhibitors. Our study provides the first proof-of-concept for developing triple-site inhibitors against aaRSs, inspiring future aaRS-based drug discoveries.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.2c00134.1H NMR and 13C NMR spectra of intermediates and target compounds; HPLC spectrum of representative compounds 36j and 36k; X-ray data collection and refinement statistics of 18a, 36a, and 36k; relationship between the MIC values and cLog P values of triple-site inhibitors; prediction of drug-likeness and ADMET properties of the representative compounds; docking spectrum of designed candidate compounds; TSA of all compounds; and inhibitory curves of SeThrRS using triple-site inhibitors 18a–c, 36a–l, 43, and 44 (PDF)Molecular formula strings (CSV)Full wwPDB X-ray structure validation report (PDF)Full wwPDB X-ray structure validation report (PDF)Full wwPDB X-ray structure validation report (PDF)This article has not yet been cited by other publications.

Evolutionary Limitation and Opportunities for Developing Trna Synthetase Inhibitors with 5-Binding-mode Classification.

Research Advances of Aminoacyl-tRNA Synthetase Inhibitors As Novel Anti-infective Agents

In Silico Discovery of Aminoacyl-tRNA Synthetase Inhibitors

Recent Development of Leucyl-Trna Synthetase Inhibitors As Antimicrobial Agents.

The Binding Mode of Orphan Glycyl-Trna Synthetase with Trna Supports the Synthetase Classification and Reveals Large Domain Movements

Aminoacyl-tRNA synthetase inhibitors as potent antibacterials.

The Canonical and Noncanonical Functions of Aminoacyl-tRNA Synthetases

New Functions of Aminoacyl-Trna Synthetases Beyond Translation

Family-wide analysis of aminoacyl-sulfamoyl-3-deazaadenosine analogues as inhibitors of aminoacyl-tRNA synthetases

Ligand co-crystallization of aminoacyl-tRNA synthetases from infectious disease organisms

Discovery of Novel Trna-Amino Acid Dual-Site Inhibitors Against Threonyl-Trna Synthetase by Fragment-Based Target Hopping.

Synthesis and Biological Evaluation of 1,3-Dideazapurine-Like 7-Amino-5-Hydroxymethyl-Benzimidazole Ribonucleoside Analogues as Aminoacyl-tRNA Synthetase Inhibitors

Strategies for Detecting Aminoacylation and Aminoacyl‐tRNA Editing In Vitro and In Cells

Coexisting bacterial aminoacyl‐tRNA synthetase paralogs exhibit distinct phylogenetic backgrounds and functional compatibility with Escherichia coli

Homeostatic mechanisms by alternative forms of tRNA synthetases.

Aminoacyl-tRNA synthetase evolution and sectoring of the genetic code

Peculiarities of aminoacyl-tRNA synthetases from trypanosomatids

Design, Synthesis, and Proof-of-Concept of Triple-Site Inhibitors against Aminoacyl-tRNA Synthetases

Physiological and engineered tRNA aminoacylation

High-Throughput Aminoacyl-tRNA Synthetase Engineering for Genetic Code Expansion in Yeast

The Yin and Yang of Trna: Proper Binding of Acceptor End Determines the Catalytic Balance of Editing and Aminoacylation